GelMEDIX Alternatives & Competitors

10 companies similar to GelMEDIX — Technology to revolutionize ocular cell therapies

Beacon Therapeutics

Transforming Vision, Transforming Lives

95 Series C $341.00M

London, United Kingdom

Biotechnology Health Care +1

Vedere Bio II

Bringing vision back to life.

2 Series A $98.00M

Cambridge, United States

Biotechnology Health Care +1

Ray Therapeutics, Inc.

Optogenetic Gene Therapy Company

46 Series B $235.00M

Berkeley, United States

Biotechnology Health Care +2

Angiocrine Bioscience, Inc.

Transforming medicine through engineered cellular therapies that restore, regenerate, and...

21 Grant $77.12M

San Diego, United States

Biotechnology Health Care +1

Track all GelMEDIX competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Ethris

Clinical stage biotech company focused on development of disruptive mRNA therapeutics for...

34 Venture round $84.80M

Planegg, Germany

Biopharma Biotechnology +2

Satellite Bio

Tackling some of humankind’s most elusive diseases with Tissue Therapeutics, a new categor...

24 Series A $110.00M

Cambridge, United States

Biotechnology Pharmaceutical

Adverum Biotechnologies

We are on a global mission to establish gene therapy as a new standard of care for the lea...

133 Acquired $814.90M

Redwood City, United Stat...

Biotechnology Health and Wellness +1

Jellatech

Real Collagen. No Compromise.

9 Seed $5.50M

Raleigh, United States

Biotechnology Food and Beverage +2

Strand Therapeutics

Where synthetic biology meets RNA therapeutics

121 Series A $104.20M

Boston, United States

Biotechnology Health and Wellness +2

Alaunos Therapeutics

Attacking solid tumors with TCRs

10 Post-IPO Equity $293.39M

Houston, United States

Biotechnology Health and Wellness +1

About GelMEDIX

GelMEDIX Inc. is an early-stage biotechnology company with the slogan "Technology to revolutionize ocular cell therapies." Founded in 2020 in the United States, GelMEDIX leverages its proprietary photo-crosslinked hydrogels to develop ocular and regenerative therapies that aim to restore vision. The company's approach...

Business keywords

Ocular Cell Therapy, Regenerative Therapy, Hydrogel Platform, Vision Restoration, Macular Degeneration, Dry AMD, GA, Tissue Regeneration, Bioadhesion, Tunable Mechanics, Therapeutic Loading, Cell Therapy, Gene Therapy, Small Molecule Therapy

Frequently Asked Questions

Companies similar to GelMEDIX include Beacon Therapeutics, Vedere Bio II, Ray Therapeutics, Inc., Angiocrine Bioscience, Inc., Ethris. They work in Biotechnology and Pharmaceutical and share GelMEDIX's focus on gene therapy, vision restoration and cell therapy.

Bounce Watch lists 10 companies that share GelMEDIX's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches GelMEDIX and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

GelMEDIX Profile Beacon Therapeutics Alternatives Ray Therapeutics, Inc. Alternatives Angiocrine Bioscience, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at GelMEDIX on 11 Sep 2024. The 10 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.